MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-151

  1. 155 Posts.
    lightbulb Created with Sketch. 37
    /If they rejected this treatment, due to assays, unknown MOA, or any other beefs, they are dooming thousands of everyday Americans to death and/or bankruptcy, and perpetuating a MASSIVE financial and resource strain on the entire US medical system. /

    correct. They want to cool the economy down imho, so they are not in a hurry to find a treatment for next Week 1-2 years.

    Better to go to Europe now & USA in 2 years.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.